Access cutting-edge mash treatment through this clinical trial at a research site in Flagstaff. Study-provided care at no cost to qualified participants.
Access mash specialists in Flagstaff at no cost
This study follows strict safety protocols and ethical guidelines
All study-related mash treatment provided free
This study is researching an investigational drug, ALN-HSD called "study drug". This study is focused on participants who are known to have metabolic dysfunction-associated steatohepatitis (MASH). MASH is a form of metabolic dysfunction-associated steatotic liver disease (MASLD). MASH occurs when fat builds up in liver cells, damaging them, and making the liver inflamed and stiff from fibrosis (scar tissue). MASH can progress to cirrhosis (long term scarring) and liver failure (when the liver ca
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this mash clinical trial in Flagstaff, AZ
If you're searching for mash treatment options in Flagstaff, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Flagstaff research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mash specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.